Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Elisa Biotech
Wuhan, Hubei, Chinaelisabiotech.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Elisa Biotech is a life science company based in Wuhan, China, specializing in the development and manufacturing of high-quality biological reagents. The company primarily focuses on Enzyme-Linked Immunosorbent Assay (ELISA) kits, recombinant proteins, and antibodies for research use across various species including human, mouse, rat, and bovine. Their product portfolio supports research in areas such as immunology, oncology, and cell biology, providing tools for academic and industrial laboratories worldwide. Elisa Biotech is recognized for its extensive catalog of diagnostic and research kits that facilitate the detection of cytokines, hormones, and other biomarkers.
- Modalities
- AntibodyProteinRecombinant protein
- Industry
- Protein Biomarker Diagnostics
Beyond the preview
Go deeper on Elisa Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Elisa Biotech.